Evidence map›Paper›PMID 24983460›Full record

ArticlePloS one2014

An unstable Th epitope of P. falciparum fosters central memory T cells and anti-CS antibody responses.

Carlos A Parra-López, David Bernal-Estévez, Liusong Yin, Luis Eduardo Vargas, Carolina Pulido-Calixto, Luz Mary Salazar, J Mauricio Calvo-Calle, Lawrence J Stern

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

  • Erratum issued
    Yin, Liusong [added]
5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Carlos A Parra-LópezDepartment of Microbiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia; Graduate School in Biomedical Sciences, Universidad Nacional de Colombia, Bogotá, Colombia.
David Bernal-EstévezDepartment of Microbiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia; Graduate School in Biomedical Sciences, Universidad Nacional de Colombia, Bogotá, Colombia; Fundación Salud de los Andes, Research Group of Immunology and Clinical Oncology - GIIOC, Bogotá, Colombia.
Liusong Yin
Luis Eduardo VargasDepartment of Microbiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
Carolina Pulido-CalixtoDepartment of Microbiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
Luz Mary SalazarFaculty of Sciences, Universidad Nacional de Colombia, Bogotá, Colombia.
J Mauricio Calvo-CalleUniversity of Massachusetts Medical School, Department of Pathology and Biochemistry and the Department of Molecular Pharmacology, Worcester, Massachusetts, United States of America.
Lawrence J SternUniversity of Massachusetts Medical School, Department of Pathology and Biochemistry and the Department of Molecular Pharmacology, Worcester, Massachusetts, United States of America.
Universidad Nacional de Colombia · COUniversity of Massachusetts Chan Medical School · US

Funding

Structure and Function of MHC ProteinsR37AI038996 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 2008 to 2017
$4.1M
Structure and Function of Class II MHC ProteinsR01AI038996 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J · 1996 to 2006
$1.6M
Structure and Function of Class II MHC ProteinsR56AI038996 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J · 2007 to 2007
$324k
NIAID NIH HHS AI38996NIAID NIH HHS R01 AI038996NIAID NIH HHS R37 AI038996NIAID NIH HHS R56 AI038996PHS HHS U19-57319
6 · The paper itself

Abstract

Malaria is transmitted by Plasmodium-infected anopheles mosquitoes. Widespread resistance of mosquitoes to insecticides and resistance of parasites to drugs highlight the urgent need for malaria vaccines. The most advanced malaria vaccines target sporozoites, the infective form of the parasite. A major target of the antibody response to sporozoites are the repeat epitopes of the circumsporozoite (CS) protein, which span almost one half of the protein. Antibodies to these repeats can neutralize sporozoite infectivity. Generation of protective antibody responses to the CS protein (anti-CS Ab) requires help by CD4 T cells. A CD4 T cell epitope from the CS protein designated T* was previously identified by screening T cells from volunteers immunized with irradiated P. falciparum sporozoites. The T* sequence spans twenty amino acids that contains multiple T cell epitopes restricted by various HLA alleles. Subunit malaria vaccines including T* are highly immunogenic in rodents, non-human primates and humans. In this study we characterized a highly conserved HLA-DRβ1*04:01 (DR4) restricted T cell epitope (QNT-5) located at the C-terminus of T*. We found that a peptide containing QNT-5 was able to elicit long-term anti-CS Ab responses and prime CD4 T cells in HLA-DR4 transgenic mice despite forming relatively unstable MHC-peptide complexes highly susceptible to HLA-DM editing. We attempted to improve the immunogenicity of QNT-5 by replacing the P1 anchor position with an optimal tyrosine residue. The modified peptide QNT-Y formed stable MHC-peptide complexes highly resistant to HLA-DM editing. Contrary to expectations, a linear peptide containing QNT-Y elicited almost 10-fold lower long-term antibody and IFN-γ responses compared to the linear peptide containing the wild type QNT-5 sequence. Some possibilities regarding why QNT-5 is more effective than QNT-Y in inducing long-term T cell and anti-CS Ab when used as vaccine are discussed.

Indexed as

Immunologic MemoryAnimalsAntibodies, ProtozoanCD4-Positive T-LymphocytesEpitopes, T-LymphocyteFemaleHLA-DR4 AntigenHumansMalaria VaccinesMaleMiceMice, TransgenicPlasmodium falciparumProtein StabilityProtozoan ProteinsAntibodies, Protozoancircumsporozoite protein, ProtozoanEpitopes, T-LymphocyteHLA-DR4 AntigenMalaria VaccinesProtozoan Proteins

Identifiers

PMID24983460
PMCPMC4077652
OpenAlexW2124701722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.